Industri

Tariffs & sustainability: Why Indian pharma can no long...

For a long time, Indian pharmaceutical companies could treat trade policy as a ...

India is well on its path to strongly push back the per...

As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISC...

Next Generation Dovetail Deck and Pintail Anchors

Vulcraft-Verco developed the PinTail™ Anchor: a robust hanging solution designed...

HAB Pharma completes strategic merger with Signature Ph...

HAB Pharma and Signature Phytochemicals have completed a strategic merger throu...

VERTANICAL’s VER-01 gains FDA breakthrough status for l...

The designation follows two randomised, controlled Phase III trials that showed ...

Regeneron signs $2.32bn deal with Parabilis for Helicon...

Helicons are stabilised, cell-penetrant alpha-helical peptides engineered to int...

Parexel launches ParexelAI to accelerate clinical devel...

Parexel, a leading global clinical development partner providing insights-drive...

Glenmark USA launches Vancomycin Hydrochloride for inje...

Glenmark Pharmaceuticals USA announced the launch of Vancomycin Hydrochloride f...

Lupin receives tentative approval from US FDA for Revef...

Global pharma major, Lupin announced that it has received tentative approval fr...

General Leonard Wood Community Hospital Opens at Fort L...

After six years of construction, Fort Leonard Wood marked the opening of the new...

Flat Handrail

Wallprotex’s wX7 Flat Handrail is a commercial vinyl handrail designed for high-...

Powering the Future of Cognitive Care at USC’s New Brai...

Located on its Health Sciences Campus in Columbia, S.C., the University of South...

Alexandria Supino on Leading Gresham Smith’s Charlotte ...

Alexandria Supino, AIA, NCARB, EDAC, recently joined Gresham Smith’s Charlotte, ...

DesignGroup Welcomes Christian Kyle Jordan Perry as Sen...

Christian Kyle Jordan Perry recently joined DesignGroup as Senior Lab Planner. ...

Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF

Jascayd is said to be the first phosphodiesterase 4B (PDE4B) inhibitor with anti...

Kotak Alts invests INR 200 Million in Cellogen Therapeu...

Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sci...